Clinical Trials Directory

Trials / Completed

CompletedNCT05478863

The Pharmacodynamics of Cannabinoid-Caffeine Combinations

A Double-Blind, Randomized, Placebo-Controlled, Within-Subject Crossover Study of the Effects of Combinations of Cannabinoids and Caffeine

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

Cannabis and caffeine are two of the most commonly consumed psychoactive substances in the world, with many consumers reporting positive impacts on energy, alertness, and focus. Preliminary evidence has suggested that cannabidiol (CBD), the non-intoxicating cannabinoid found in cannabis, may mitigate the negative side effects of caffeine (e.g., feeling jittery) without impacting positive or desired effects. CBD also shows potential in reducing undesirable acute effects (e.g., anxiety) of delta-9-tetrahydrocannabinol (THC), the primary intoxicating cannabinoid found in cannabis. Despite these promising findings, little is known about the potential effects of THC, caffeine, and CBD in combination. This double-blind, randomized, placebo-controlled, within-subject crossover study will assess the effects of combinations of THC, CBD, and caffeine (i.e., THC only; THC + caffeine; THC + CBD + caffeine) on subjective energy, arousal, and cognitive performance.

Conditions

Interventions

TypeNameDescription
DRUGOral PlaceboPlacebo will be orally self-administered by study participants.
DRUGOral THCTHC will be orally self-administered by study participants.
DRUGOral CBDCBD will be orally self-administered by study participants.
DRUGOral CaffeineCaffeine will be orally self-administered by study participants.

Timeline

Start date
2023-01-20
Primary completion
2024-10-02
Completion
2024-10-02
First posted
2022-07-28
Last updated
2024-10-08

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05478863. Inclusion in this directory is not an endorsement.